Concepedia

Melvin Fox

MF

Statistics

Publications

12

Citations

956

H-Index

12

Active since

1976

Affiliations

AbbVie (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Bristol-Myers Squibb (United States)

PDL BioPharma (United States)

Melvin Fox is an author at AbbVie (United States) specializing in medicine, radiation oncology, and cancer research.

ORCID

Top concepts

Publications per year

1976–2022

12

Publications

12

LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates

James W. Purcell, Sonia G. Tanlimco, Jonathan A. Hickson et al. · Cancer Research · 2018 · 189 citations

Molecular and Cellular Aspects of Carcinogen Screening Tests

Melvin Fox · British Journal of Cancer · 1981 · 166 citations · Full text

, , +7

Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways

Balaji Balasa, Rui Yun, Nicole A. Belmar et al. · Cancer Immunology Immunotherapy · 2014 · 152 citations · Full text

Screening Tests in Chemical Carcinogenesis

Melvin Fox · British Journal of Cancer · 1976 · 91 citations · Full text

, , +7

A function blocking anti-mouse integrin α5β1 antibody inhibits angiogenesis and impedes tumor growth in vivo

Vinay Bhaskar, Dong Zhang, Melvin Fox et al. · Journal of Translational Medicine · 2007 · 79 citations · Full text

1–5 of 12